CTI BIOPHARMA CORP Underwriting Agreements
7 Contracts & Agreements
- Underwriting Agreement by and among the Company and the Representatives, dated as of March 31, 2021 (Filed With SEC on April 6, 2021)
- 22,500 Shares CTI BioPharma Corp. Series N-3 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on June 9, 2017)
- 55,000 Shares CTI BioPharma Corp. Series N-2 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on December 9, 2015)
- 50,000 Shares CTI BioPharma Corp. Series N-1 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on October 30, 2015)
- 60,000 Shares Cell Therapeutics, Inc. Series 17 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on October 11, 2012)
- Underwriting Agreement (Filed With SEC on July 28, 2009)
- UNDERWRITING AGREEMENT (Filed With SEC on August 6, 2004)
